Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,811 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $639.39 | 6 | $0 (2024) |
| ABBVIE INC. | $300.07 | 3 | $0 (2023) |
| Alcresta Therapeutics, Inc. | $183.41 | 4 | $0 (2024) |
| Fresenius Kabi USA, LLC | $152.56 | 1 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $124.88 | 1 | $0 (2021) |
| Novo Nordisk Inc | $123.11 | 1 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $113.34 | 1 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $95.18 | 1 | $0 (2024) |
| Esperion Therapeutics, Inc. | $79.20 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $220.74 | 3 | AstraZeneca Pharmaceuticals LP ($96.66) |
| 2023 | $556.62 | 6 | Alcresta Therapeutics, Inc. ($154.51) |
| 2022 | $106.26 | 1 | AstraZeneca Pharmaceuticals LP ($106.26) |
| 2021 | $927.52 | 9 | AstraZeneca Pharmaceuticals LP ($311.45) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $96.66 | General |
| Category: Respiratory | ||||||
| 03/20/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $95.18 | General |
| Category: Neurology | ||||||
| 01/24/2024 | Alcresta Therapeutics, Inc. | RELIZORB (Device) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $125.02 | General |
| Category: Respiratory | ||||||
| 10/05/2023 | Alcresta Therapeutics, Inc. | RELIZORB (Device) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $124.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/06/2023 | Alcresta Therapeutics, Inc. | RELIZORB (Device) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/02/2023 | Alcresta Therapeutics, Inc. | RELIZORB (Device) | Food and Beverage | In-kind items and services | $100.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2023 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Food and Beverage | In-kind items and services | $152.56 | General |
| Category: Parental Nutrition | ||||||
| 03/08/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $106.26 | General |
| Category: Respiratory | ||||||
| 12/07/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $60.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/16/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/19/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $123.11 | General |
| Category: Diabetes | ||||||
| 10/05/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $124.88 | General |
| Category: PRIMARY CARE | ||||||
| 09/21/2021 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $79.20 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/20/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $113.34 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $115.13 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $90.88 | General |
| Category: Respiratory | ||||||
| 03/25/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $95.57 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 51 | $11,628 | $3,996 |
| 2022 | 1 | 12 | 93 | $21,204 | $6,428 |
| 2021 | 1 | 12 | 12 | $2,724 | $824.04 |
| 2020 | 1 | 18 | 118 | $27,848 | $8,331 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 51 | $11,628 | $3,996 | 34.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 93 | $21,204 | $6,428 | 30.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 12 | 12 | $2,724 | $824.04 | 30.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 18 | 118 | $27,848 | $8,331 | 29.9% |
About Ajanta Raman, APRN
Ajanta Raman, APRN is a Medical-Surgical healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2017. The National Provider Identifier (NPI) number assigned to this provider is 1003335803.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ajanta Raman, APRN has received a total of $1,811 in payments from pharmaceutical and medical device companies, with $220.74 received in 2024. These payments were reported across 19 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,811).
As a Medicare-enrolled provider, Raman has provided services to 53 Medicare beneficiaries, totaling 274 services with total Medicare billing of $19,579. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Medical-Surgical
- Other Specialties Adult Health
- Location Kansas City, MO
- Active Since 09/12/2017
- Last Updated 11/18/2025
- Taxonomy Code 163WM0705X
- Entity Type Individual
- NPI Number 1003335803
Products in Payments
- BREZTRI (Drug) $197.14
- RELIZORB (Device) $183.41
- Smoflipid (Drug) $152.56
- FASENRA (Biological) $125.02
- FARXIGA (Drug) $125.00
- NURTEC ODT (Drug) $124.88
- LINZESS (Drug) $124.53
- RYBELSUS (Drug) $123.11
- UBRELVY (Drug) $115.13
- SOLIQUA 100/33 (Biological) $113.34
- AIRSUPRA (Drug) $96.66
- UZEDY (Drug) $95.18
- NEXLIZET (Drug) $79.20
- CREON (Drug) $60.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical-Surgical Doctors in Kansas City
Deborah Summers, Aprn-Bc, APRN-BC
Medical-Surgical — Payments: $1,399
Laura Selanders
Medical-Surgical — Payments: $299.24
Vicki Nower, Aprn, APRN
Medical-Surgical — Payments: $59.80
Janice Dennis, Rn, Bc, M-Scns, RN, BC, M-SCNS
Medical-Surgical — Payments: $48.05
Ms. Nadine Nuss
Medical-Surgical
Marcia Beck, Aprn, Bc, APRN, BC
Medical-Surgical